Evidence map›Paper›PMID 27851964›Full record

ArticleCell reports2016

CAPS1 RNA Editing Promotes Dense Core Vesicle Exocytosis.

Kotaro Miyake, Toshio Ohta, Hisako Nakayama, Nobutaka Doe, Yuri Terao, Eiji Oiki, Izumi Nagatomo, Yui Yamashita, Takaya Abe, Kazuko Nishikura and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Evolution of Engineered ADAR-Based RNA Editing Systems.International journal of molecular sciences · 2026
    Review
  3. Review
  4. Article
  5. Experimental evidence for the functional importance and adaptive advantage of A-to-I RNA editing in fungi.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Adenosine-to-inosine RNA editing in the immune system: friend or foe?Cellular and molecular life sciences : CMLS · 2020
    Review
  14. Article
  15. CAPS1 Suppresses Tumorigenesis in Cholangiocarcinoma.Digestive diseases and sciences · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Kotaro MiyakeDepartment of RNA Biology and Neuroscience, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan; Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Toshio OhtaDepartment of Veterinary Pharmacology, Faculty of Agriculture, Tottori University, Tottori, Tottori 680-8553, Japan.
Hisako NakayamaDepartment of Neurophysiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Hiroshima 734-8551, Japan.
Nobutaka DoeGeneral Education Center, Hyogo University of Health Sciences, Kobe, Hyogo 650-8530, Japan.
Yuri TeraoCenter for Medical Research and Education, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Eiji OikiCenter for Medical Research and Education, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Izumi NagatomoDepartment of Respiratory Medicine, Allergy and Rheumatic Diseases, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Yui YamashitaAnimal Resource Development Unit, RIKEN Center for Life Science Technologies, Kobe, Hyogo 650-0047, Japan; Genetic Engineering Team, RIKEN Center for Life Science Technologies, Kobe, Hyogo 650-0047, Japan.
Takaya AbeGenetic Engineering Team, RIKEN Center for Life Science Technologies, Kobe, Hyogo 650-0047, Japan.
Kazuko NishikuraThe Wistar Institute, Philadelphia, PA 19104, USA.
Atsushi KumanogohDepartment of Respiratory Medicine, Allergy and Rheumatic Diseases, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan.
Kouichi HashimotoDepartment of Neurophysiology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Hiroshima 734-8551, Japan.
Yukio KawaharaDepartment of RNA Biology and Neuroscience, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan. Electronic address: ykawahara@rna.med.osaka-u.ac.jp.
Osaka University · JPHiroshima University · JPHyogo University of Health Sciences · JPThe Wistar Institute · USTottori University · JP

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
STRUCTURE AND FUNCTION OF DSRNA ADENOSINE DEAMINASER01GM040536 · NIGMS · WISTAR INSTITUTE · PI NISHIKURA, KAZUKO · 1991 to 2021
$8.1M
Control of Breast Cancer Metastasis by Epstein-Barr Virus microRNAR01CA175058 · NCI · WISTAR INSTITUTE · PI NISHIKURA, KAZUKO · 2014 to 2018
$2.0M
NCI NIH HHS P30 CA010815NCI NIH HHS R01 CA175058NIGMS NIH HHS R01 GM040536
6 · The paper itself

Abstract

Calcium-dependent activator protein for secretion 1 (CAPS1) plays a distinct role in the priming step of dense core vesicle (DCV) exocytosis. CAPS1 pre-mRNA is known to undergo adenosine-to-inosine RNA editing in its coding region, which results in a glutamate-to-glycine conversion at a site in its C-terminal region. However, the physiological significance of CAPS1 RNA editing remains elusive. Here, we created mutant mice in which edited CAPS1 was solely expressed. These mice were lean due to increased energy expenditure caused by physical hyperactivity. Electrophysiological and biochemical analyses demonstrated that the exocytosis of DCVs was upregulated in the chromaffin cells and neurons of these mice. Furthermore, we showed that edited CAPS1 bound preferentially to the activated form of syntaxin-1A, a component of the exocytotic fusion complex. These findings suggest that RNA editing regulates DCV exocytosis in vivo, affecting physical activity.

Indexed as

ExocytosisAdenosine DeaminaseAnimalsBiocatalysisBody WeightCalcium-Binding ProteinsCatecholaminesEnergy MetabolismMaleMiceMice, Mutant StrainsNerve Tissue ProteinsNucleic Acid ConformationPC12 CellsPhysical Conditioning, AnimalProtein BindingADAR1 protein, mouseADAR2 protein, mouseAdenosine DeaminaseCadps protein, mouseCalcium-Binding ProteinsCatecholaminesNerve Tissue ProteinsRNA-Binding ProteinsRNA, MessengerSyntaxin 1ADARcatecholaminedense core vesicleexocytosispost-transcriptional modificationsyntaxin-1A

Identifiers

PMID27851964
PMCPMC5199237
OpenAlexW2556542827

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.